Allan Hildesheim

Senior Investigator
Division of Cancer Epidemiology, Infections and Immunoepidem
National Cancer Institute
United States of America

Scientist Medical Sciences
Biography

Dr. Hildesheim was Chief of the Infections and Immunoepidemiology Branch from 2008-2017. He received his Ph.D. in epidemiology from The Johns Hopkins School of Hygiene and Public Health in 1991 and has been at the NCI since 1987. Dr. Hildesheim's research focuses on understanding host and viral factors involved in the pathogenesis of DNA virus-related tumors and in the evaluation of efficacy and underlying immunological mechanisms associated with licensed prophylactic HPV vaccines

Research Intrest

Cervical Cancer; HPV Vaccines; Nasopharyngeal Cancer

List of Publications
Chang C, Middeldorp J, Yu KJ, Juwana H, Hsu WL, Lou PJ, Wang CP, Chen JY, Liu MY, Pfeiffer RM, Chen CJ. Characterization of ELISA detection of broad‐spectrum anti‐Epstein–Barr virus antibodies associated with nasopharyngeal carcinoma. Journal of medical virology. 2013 Mar 1;85(3):524-9.
Hildesheim A. Invited commentary: Epstein-Barr virus–based screening for the early detection of nasopharyngeal carcinoma—a new frontier. American journal of epidemiology. 2012 Dec 19;177(3):251-3.
Hildesheim A, de González AB. Etiology and prevention of cervical adenocarcinomas.

Global Scientific Words in Medical Sciences